Moors & Cabot, Inc. Astrazeneca PLC Put Options Transaction History
Moors & Cabot, Inc.
- $1.85 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AZN
# of Institutions
1,343Shares Held
492MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.88 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.2 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.05 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.76 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.32 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...